Piedmont Investment Advisors’s Array Biopharma Inc ARRY Stock Holding History

Piedmont Investment Advisors’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-7,479	Closed	-$347K	–	949
2019 Q2	$347K	Buy	+7,479	New	+$210K	0.01%	711
2018 Q3	–	Sell	-3,540	Closed	-$59K	–	2816
2018 Q2	$59K	Buy	+3,540	New	+$56.3K	﹤0.01%	1236

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Piedmont Investment Advisors's ARRY Position: Q3 2019 in Review

Piedmont Investment Advisors sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 7,479 shares — an estimated $347K sold.

Piedmont Investment Advisors first reported a position in ARRY in Q2 2018 and held it in 2 quarters. The position peaked at $347K in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Piedmont Investment Advisors reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Piedmont Investment Advisors sold 7,479 Array Biopharma Inc shares in Q3 2019, an estimated $347K.
Piedmont Investment Advisors first reported a position in Array Biopharma Inc in Q2 2018 and held it in 2 quarters.
Piedmont Investment Advisors's Array Biopharma Inc position peaked at $347K in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Piedmont Investment Advisors's 13F filing for Q3 2019, filed 13 Nov 2019.